Life Sciences
The company will use the funds to grow the company, increase manufacturing operations and put in place more products in the research and development pipeline.
The partnership combines Atropos Health's expertise in real-world evidence generation with Databricks' data intelligence capabilities.
Molly Gibson, president of future science at Lila Sciences, explains how the company's superintelligence will reshape research across life, chemical and material sciences.
Manulife Group Benefits plan members will have virtual access to Maven's digital platform, connecting them to a global network of providers.
The aim is to use See-Mode's thyroid ultrasound as a way to enhance workflow and diagnostic accuracy at RadNet imaging centers.
The partnership will help self-insured employers satisfy their fiduciary obligations and lower prescription drug costs and provide members access to inexpensive medications.
HIMSS25
Jackie Rice, VP and chief information officer at Frederick Health, says adding pharmacogenetic data to the health system's EHR enables alerts that advise clinicians on how a patient’s genes can affect drug response.
Jayme Strauss, Precision Neuroscience's chief clinical and commercial officer, kicks off the Emerging Technologies series, discussing how the company's brain-computer interface, Layer 7, works and what it hopes to accomplish for patients.
The funds will be dispersed over the next five years to develop innovations aimed at enhancing the healthcare journey for patients.
The collaboration addresses delays in diagnosis and treatment by leveraging AI to help ensure patients with prostate and breast cancer are identified and treated more promptly.